FOXM1 (forkhead box M1)
2008-02-01 Jamila Laoukili  , Monica Alvarez Fernandez  , René H Medema   AffiliationDepartment of Human Genetics, Academic Medical Center, Amsterdam, The Netherlands (JL); Department of Medical Oncology, University Medical Center Utrecht, The Netherlands (MAF, RHM)
Identity
HGNC
LOCATION
12p13.33
LOCUSID
ALIAS
FKHL16,FOXM1A,FOXM1B,FOXM1C,HFH-11,HFH11,HNF-3,INS-1,MPHOSPH2,MPP-2,MPP2,PIG29,TRIDENT
FUSION GENES
DNA/RNA

Description
The gene spans 25 kb and contains 10 exons.
Transcription
3.4-3.6 kb mRNA; Differential splicing of exons Va (A1) and VIIa (A2) gives rise to 3 classes of transcripts, which encode 3 different protein isoforms: FoxM1A, containing both alternative exons; FoxM1B, containing none of the alternative exons and FoxM1C, containing only exon Va.
Proteins

hFoxM1C
Description
FoxM1 belongs to a large family of forkhead transcription factors. FoxM1 protein contains 3 main regions: the N-terminal Repressor Domain (NRD). This region is followed by a conserved DNA Binding Domain called Forkhead or winged-helix domain (FKH). The C-terminal region harbors the Transcativation Domain (TAD) with several activating Cyclin-Cdk-dependent phosphorylation sites.
Expression
FoxM1 is specifically expressed in proliferating cells. Expression is negatively regulated in quiescent or terminally-differentiated cells. Both expression and transcriptional activity of FoxM1 are tightly regulated during the cell cycle. Increase in FoxM1 expression levels is initiated at the onset of S-phase and continues throughout G2-phase and Mitosis. During G1 phase, FoxM1 activity is inhibited through several mechanisms, including interaction with the cell cycle inhibitory pocket protein pRb, and through inhibition by the N-terminal auto-repressor domain of FoxM1 itself. The cell cycle-inhibitory p19ARF can also bind the C-terminal transactivation domain of FoxM1 and inactivate its transcriptional activity by targeting FoxM1 protein to the nucleolus. Transcriptional activation of FoxM1 correlates with increased phosphorylation of the protein. It occurs specifically during G2-phase of the cell cycle through direct phosphorylation of the C-terminal transactivation domain (TAD) mediated by G2-Cyclin-dependent kinases (Cdks). Cyclin-Cdk-dependent phosphorylation of the C-terminal region of FoxM1 is required to relieve auto-inhibition exerted by the N-terminal repressor domain (NRD). In addition, Cdk-dependent phosphorylation of the C-terminal TAD serves to recruit transcriptional co-activators such as the histone deacetylase p300/CREB binding protein (p300/CBP). FoxM1 transcriptional activity also requires the presence of appropriate mitogenic signals involving the Raf/MEK/MAPK signaling pathway.
Localisation
Nuclear, but can be detected in the cytoplasm upon inhibition of Raf/MEK/MAPK signaling. FoxM1 can also be targeted to the nucleolus by p19ARF.
Function
FoxM1 acts as a transcriptional activator of the G2-M-specific gene cluster in mammalian cells.
Homology
Homology with other Forkhead transcription factors in the FKH DNA Binding Domain.
Implicated in
Entity name
Cancer
Disease
FoxM1 is commonly upregulated in human aggressive carcinomas originating from prostate, breast, lung, ovary, colon, pancreas, stomach, bladder, liver and kidney. FoxM1 promotes tumor progression of prostate carcinomas and lung adenocarcinomas. FoxM1 expression and activity are significantly elevated in basal cell carcinoma (BCC) skin tumors and FoxM1 expression in malignant gliomas correlates with disease staging. FoxM1 contributes to cellular transformation by the high-risk human papillomavirus-16 (HPV-16) E7 protein. Conditional deletion of the FoxM1 gene in mice reduces proliferation of lung tumors and renders hepatocytes resistant to tumor development. Down-regulation of FoxM1 reduces the invasiveness of glioma cells and decreases cell migration and cell invasion in pancreatic cancer cells.
Cytogenetics
Amplifications of the 12p13 chromosomal band, comprising the FoxM1 gene, have been reported in numerous tumors such as cervical squamous cell carcinomas, breast adenocarcinomas, nasopharyngeal carcinomas and head and neck squamous cell carcinomas.
Entity name
Ageing
Disease
FoxM1 expression is affected (low) in cells from patients with progeria and FoxM1-deficient cells senesce prematurely. Inversely, increased levels of FoxM1B in regenerating liver of old transgenic mice elevate hepatocyte proliferation to levels similar to those observed in young regenerating mouse liver.
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|
Other Information
Locus ID:
NCBI: 2305
MIM: 602341
HGNC: 3818
Ensembl: ENSG00000111206
Variants:
dbSNP: 2305
ClinVar: 2305
TCGA: ENSG00000111206
COSMIC: FOXM1
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37974331 | 2024 | Transcription factor FOXM1 specifies chromatin DNA to extracellular vesicles. | 0 |
| 38038123 | 2024 | Oncogenic role of FOXM1 in human prostate cancer (Review). | 0 |
| 38069906 | 2024 | Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastoma. | 0 |
| 38172354 | 2024 | FOXM1 transcriptional regulation of RacGAP1 activates the PI3K/AKT signaling pathway to promote the proliferation, migration, and invasion of cervical cancer cells. | 1 |
| 38190128 | 2024 | FOXM1 Participates in Scleral Remodeling in Myopia by Upregulating APOA1 Expression Through METTL3/YTHDF2. | 0 |
| 38338955 | 2024 | FOXM1 Participates in Trophoblast Migration and Early Trophoblast Invasion: Potential Role in Blastocyst Implantation. | 0 |
| 38342795 | 2024 | FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression. | 0 |
| 38361222 | 2024 | PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined inhibition results in synergistic anti-tumor effects. | 0 |
| 38373993 | 2024 | Epigenomic analyses identify FOXM1 as a key regulator of anti-tumor immune response in esophageal adenocarcinoma. | 0 |
| 38374400 | 2024 | FOXM1: a new therapeutic target of extramammary Paget disease. | 0 |
| 38514068 | 2024 | HNRNPC Regulates GLUT1/LDHA Pathway by Stabilizing FOXM1 mRNA to Promote the Progression and Aerobic Glycolysis of Multiple Myeloma. | 0 |
| 38566554 | 2024 | YTHDC1-dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple-negative breast cancer. | 1 |
| 38608123 | 2024 | The role of transcription factor FOXA1/C2/M1/O3/P1/Q1 in breast cancer. | 0 |
| 38678605 | 2024 | Effect of circFOXM1/miR-218-5p on the proliferation, apoptosis and migration of glioma cells. | 0 |
| 38761648 | 2024 | FOXM1 and CHD4 expression is associated with chemoresistance in hepatoblastoma. | 0 |
Citation
Jamila Laoukili ; Monica Alvarez Fernandez ; René H Medema
FOXM1 (forkhead box M1)
Atlas Genet Cytogenet Oncol Haematol. 2008-02-01
Online version: http://atlasgeneticsoncology.org/gene/40631/foxm1
